Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 173 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Roilides, Emmanuel  [Clear All Filters]
2019
Delhaes, L., Touati K., Faure-Cognet O., Cornet M., Botterel F., Dannaoui E., et al. (2019).  Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".. J Cyst Fibros. 18(2), 212-220.
Roilides, E., Carlesse F., Leister-Tebbe H., Conte U., Yan J. L., Liu P., et al. (2019).  A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.. Pediatr Infect Dis J. 38(3), 275-279.
Darda, V. Magdalini, Iosifidis E., Antachopoulos C., Volakli E., Haidich A. Bettina, Vagdatli E., et al. (2019).  Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit.. Acta Paediatr. 108(10), 1923-1924.
Bradley, J. S., Roilides E., Broadhurst H., Cheng K., Huang L-M., MasCasullo V., et al. (2019).  Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.. Pediatr Infect Dis J. 38(9), 920-928.
Folgori, L., Lutsar I., Standing J. F., A Walker S., Roilides E., Zaoutis T. E., et al. (2019).  Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.. BMJ Open. 9(12), e032592.
Athanasiadou, K. I., Athanasiadis D. I., Constantinidis J., Anastasiou A., Roilides E., & Papakonstantinou E. (2019).  Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma.. Med Mycol Case Rep. 25, 10-14.
Roilides, I., Vasilaki K., Xinias I., Iosifidis E., Antachopoulos C., & Roilides E. (2019).  Thiamine Deficiency in a Child with Short Bowel Syndrome and Review.. Pediatr Gastroenterol Hepatol Nutr. 22(5), 493-499.
Iosifidis, E., Chorafa E., Agakidou E., Kontou A., Violaki A., Volakli E., et al. (2019).  Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age.. Pediatr Infect Dis J. 38(8), 812-815.
2020
Maltezou, H. C., Magaziotou I., Dedoukou X., Eleftheriou E., Raftopoulos V., Michos A., et al. (2020).  Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads.. Pediatr Infect Dis J.
Tsiatsiou, O., Papachristou S., Papadimitriou E., Michailidou E., Chatzidimitriou D., Papa A., et al. (2020).  Epstein-Barr Encephalitis in a Child with Congenital Human Immunodeficiency Virus Infection: A Case Report Calling for No Forgetfulness.. Curr HIV Res. 18(1), 63-66.
Karampatakis, T., Tsergouli K., Iosifidis E., Antachopoulos C., Mouloudi E., Karyoti A., et al. (2020).  Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.. J Glob Antimicrob Resist. 20, 214-218.
Geladari, A., Simitsopoulou M., Antachopoulos C., & Roilides E. (2020).  Immunomodulatory Effects of Colistin on Host Responses against Carbapenem-resistant Klebsiella pneumoniae Biofilms.. Int J Antimicrob Agents. 106182.
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies. Journal of Pediatric Hematology/Oncology. Publish Ahead of Print,
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.. J Pediatr Hematol Oncol.
Papachristou, S. G., Iosifidis E., Sipsas N. V., Gamaletsou M. N., Walsh T. J., & Roilides E. (2020).  Management of osteoarticular fungal infections in the setting of immunodeficiency.. Expert Rev Anti Infect Ther. 18(5), 461-474.
Lutsar, I., Chazallon C., Trafojer U., de Cabre V. Meiffredy, Auriti C., Bertaina C., et al. (2020).  Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.. PLoS One. 15(3), e0229380.
Hill, L. F., Turner M. A., Lutsar I., Heath P. T., Hardy P., Linsell L., et al. (2020).  An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled tria. Trials. 21(1), 329.
Voulgaridou, A., Athanasiadou K. I., Athanasiadou E., Roilides E., & Papakonstantinou E. (2020).  Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia.. Diseases. 8(3), 
Roilides, E., Carlesse F., Tawadrous M., Leister-Tebbe H., Conte U., Raber S., et al. (2020).  Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia.. Pediatr Infect Dis J. 39(4), 305-309.
Li, G., Bielicki J. Anna, Ahmed A. S. M. Nawsha, Islam M. Shahidul, Berezin E. Naaman, Gallacci C. B., et al. (2020).  Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.. Arch Dis Child. 105(1), 26-31.
Maltezou, H. C., Vorou R., Papadima K., Kossyvakis A., Spanakis N., Gioula G., et al. (2020).  Transmission dynamics of SARS-CoV-2 within families with children in Greece: A study of 23 clusters.. J Med Virol.
2022
Panagopoulou, P., & Roilides E. (2022).  Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections.. Expert Opin Pharmacother. 23(2), 175-199.
Gavriilaki, E., Tsiftsoglou S. A., Touloumenidou T., Farmaki E., Panagopoulou P., Michailidou E., et al. (2022).  Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.. Curr Issues Mol Biol. 44(7), 2811-2824.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές